Disruption of Growth Hormone Receptor Prevents Calorie Restriction from Improving Insulin Action and Longevity by Bonkowski, Michael S. et al.
Disruption of Growth Hormone Receptor Prevents
Calorie Restriction from Improving Insulin Action and
Longevity
Michael S. Bonkowski
1,2, Fernando P. Dominici
3, Oge Arum
1, Juliana S. Rocha
1,4, Khalid A. Al Regaiey
1,5,
Reyhan Westbrook
1, Adam Spong
1, Jacob Panici
1, Michal M. Masternak
1, John J. Kopchick
6, Andrzej
Bartke
1,2*
1Department of Internal Medicine – Geriatrics Research, Southern Illinois University School of Medicine, Springfield, Illinois, United States of America, 2Department of
Pharmacology, and Physiology, Southern Illinois University School of Medicine, Springfield, Illinois, United States of America, 3Instituto de Quı ´mica y Fisicoquı ´mica
Biolo ´gicas (IQUIFIB), Facultad de Farmacia y Bioquı ´mica, Universidad de Buenos Aires, Buenos Aires, Argentina, 4Department of Morphology, Laboratory of Cellular
Biology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil, 5Department of Physiology, College of Medicine, King Saud University,
Riyadh, Saudi Arabia, 6Department of Biomedical Sciences, Edison Biotechnology Institute, Ohio University, Athens, Ohio, United States of America
Abstract
Most mutations that delay aging and prolong lifespan in the mouse are related to somatotropic and/or insulin signaling.
Calorie restriction (CR) is the only intervention that reliably increases mouse longevity. There is considerable phenotypic
overlap between long-lived mutant mice and normal mice on chronic CR. Therefore, we investigated the interactive effects
of CR and targeted disruption or knock out of the growth hormone receptor (GHRKO) in mice on longevity and the insulin
signaling cascade. Every other day feeding corresponds to a mild (i.e. 15%) CR which increased median lifespan in normal
mice but not in GHRKO mice corroborating our previous findings on the effects of moderate (30%) CR on the longevity of
these animals. To determine why insulin sensitivity improves in normal but not GHRKO mice in response to 30% CR, we
conducted insulin stimulation experiments after one year of CR. In normal mice, CR increased the insulin stimulated
activation of the insulin signaling cascade (IR/IRS/PI3K/AKT) in liver and muscle. Livers of GHRKO mice responded to insulin
by increased activation of the early steps of insulin signaling, which was dissipated by altered PI3K subunit abundance
which putatively inhibited AKT activation. In the muscle of GHRKO mice, there was elevated downstream activation of the
insulin signaling cascade (IRS/PI3K/AKT) in the absence of elevated IR activation. Further, we found a major reduction of
inhibitory Ser phosphorylation of IRS-1 seen exclusively in GHRKO muscle which may underpin their elevated insulin
sensitivity. Chronic CR failed to further modify the alterations in insulin signaling in GHRKO mice as compared to normal
mice, likely explaining or contributing to the absence of CR effects on insulin sensitivity and longevity in these long-lived
mice.
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Introduction
A vast majority of the mutations that delay aging and prolong
lifespan in the mouse (Mus musculus) either directly or indirectly alter
somatotropic and/or insulin signaling [1,2]. There is considerable
intra- and extra-cellular crosstalk between growth hormone (GH),
insulin-like growth factor 1 (IGF-1), and insulin inmediating growth
and metabolism in mammals [3]. These signaling pathways are
highly conserved across phyla; and mutations affecting homologous
IGF-1/insulin-like signaling and downstream gene expression
increase longevity in yeast (Saccharomyces cerevisiae), worms (Caenor-
habditis elegans), and flies (Drosophila melanogaster) [4,5]. Taken
together, the above-mentioned findings posit GH/IGF-1/insulin
(and homologous) signaling as one of the key mediators of longevity.
Calorie restriction (CR) is the only environmental treatment
known to consistently increase average and maximal lifespan and
delay aging in organisms ranging from yeast to mammals [6,7]. In
addition to extended longevity and reduced cancer incidence, the
most consistent responses to CR in mammals include reductions in
peripheral (i.e. blood) insulin, GH, IGF-1, and glucose levels [6,8].
These biomarkers of a ‘‘CR response’’ are reported in species
ranging from mice to humans [4]. Interestingly, there is
considerable phenotypic overlap between mice on CR and many
long-lived mutant mice. These similarities include reductions in
body weight, body size, neoplastic disease incidence, peripheral
GH/IGF1, insulin, and glucose, relative to their respective
controls [9–11]. In addition, most of the long-lived mutant mice
and mice on long-term CR show improvements in insulin
sensitivity, feed efficiency and health-span. These similarities
suggest that studying interactions between the life-extending
mutations and CR may reveal what pathways and mechanisms
are utilized by CR to alter aging.
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developed by targeted disruption of the GHR/GHBP gene [12].
This insertion mutation renders the GH receptor nonfunctional
and causes severe GH resistance, leading to suppression of
peripheral IGF-1 and insulin levels. In addition, GHRKO mice
are markedly insulin-sensitive, tend to be hypoglycemic, have
reduced body weight and size, reduced incidence of neoplastic
disease and a pronounced increase in all lifespan parameters,
including increased mortality rate doubling time (MRDT), as well
as median, average and maximal lifespan [10,13,14]. We
previously reported that in contrast to hypopituitary, GH-deficient
Ames dwarf mice [15], GHRKO mice did not receive a CR
benefit in insulin sensitivity and most measures of longevity [16].
From a genetic perspective, these findings suggest that CR may
work partially via GH signaling to mediate improvements in
insulin sensitivity and extended lifespan, especially since it is well
known that GH can induce insulin resistance [17–19]. One
possible caveat is that when using a single level of CR, it is difficult
to conclude whether the mutation ablates the effects of CR at all
‘‘doses’’ (i.e., flat-lines the dose-response curve) or if the mutation
altered (or shifted) the CR dose response curve [20]. While both
outcomes are important, the former would implicate GHR-based
signaling as the paramount pathway controlling the effects of CR
on aging and lifespan in mice and thus potentially one of the
pathways that may be exploited to induce CR-like effects in
humans.
We report here two long-term studies, of the interaction
between GHR disruption and CR in male mice that were designed
to address the following questions: 1) Does the GHRKO mutation
modulate or completely ablate the benefits of CR on lifespan? 2)
How does CR improve insulin sensitivity and longevity in normal
mice? 3) Why does CR fail to improve insulin sensitivity and
longevity in GHRKO mice?
Results and Discussion
Longevity characteristics of normal and GHRKO mice on
mild CR
To determine whether the previously documented differential
responses of GHRKO and normal (N) mice to 30% CR may have
been limited to this level of dietary restriction, we conducted an
additional longevitystudyusinga milderdegreeofCRinboth mice.
Everyotherday(EOD) feedingresultedinapproximatelya 10–15%
reduction in the average daily food intake compared to ad libitum
(AL) control mice (data not shown) [21,22]. In normal male mice,
EOD feeding led to a 16% increase in median lifespan (N
AL=851 days vs. N EOD=1010 days, hazard ratio (HR) 2.62
confidence interval (CI) 1.31–6.03). In contrast, median lifespan of
GHRKO mice was not extended (KO AL=1178 days vs. KO
EOD=1158 days, HR 1.063, CI 0.50–2.29). Compared to N AL
mice, EOD feeding increased overall lifespan in normal mice as
evaluated by log-rank analysis (P,0.008); however, there were no
significantdieteffectsinGHRKOmice(P=0.6727).Thus,amilder
and different form of CR that increased longevity in normal control
mice failed to further increase the lifespan of long-lived GHRKO
mice,corroboratingourpreviousfindingsusingamoresevere(30%)
traditional CR regimen [16]. Taken together, these studies indicate
that GH resistance ablates rather than modulates (or shifts) the
benefits of CR on longevity in male GHRKO mice.
Effects of long-term 30% CR on metabolic characteristics
of normal and GHRKO mice
To search for potential mechanisms for the differential
responses of GHRKO and normal mice to CR and to further
investigate the interaction between CR, GH resistance and insulin
sensitivity, 30% CR was initiated at 2 months of age and
maintained for one year in normal and GHRKO male mice. In
comparison to animals fed AL, CR produced the expected
decrease in body weight trajectory in both normal and GHRKO
mice (Figure 1A). Furthermore, we fasted mice in all groups
overnight to determine body weight in the non-fed state.
Compared to AL controls, one year of 30% CR led to reduced
fasted body weight in both normal and GHRKO mice (Figure 1B).
There were no significant differences in the fasted peripheral
glucose levels in any of the groups tested (Figure 1C). In normal
mice, CR decreased the level of fasted insulin (P,0.001), while
both AL and CR GHRKO mice had reduced insulin levels
compared to normal mice on either diet (P,0.001 for each
comparison). Calorie restriction did not further decrease fasted
peripheral insulin levels in GHRKO mice (Figure 1D).
The relationship between peripheral glucose and insulin levels is
an important indicator of the overall insulin sensitivity of the
animal. One model that utilizes fasted glucose and insulin levels to
represent the whole organism’s insulin sensitivity is the Homeo-
static Model of Assessment (HOMA), with a relatively lower score
representing improved insulin sensitivity. Figure 1E shows that in
normal mice, one year of CR led to a reduction in the HOMA
score compared to AL controls (P,0.01), while CR did not alter
the already improved HOMA score in GHRKO mice.
To summarize, CR reduced body weight in both phenotypes
and improved fasting insulin sensitivity in normal mice, but failed
to further improve the already insulin-sensitive status of GHRKO
mice, thus uncoupling the effects of CR on body weight/growth
from its effects on insulin sensitivity and lifespan. To further
explore the interaction between GH resistance, CR, and insulin
sensitivity, we investigated the activation state of the insulin
signaling cascade in these groups in response to an exogenous
insulin challenge.
Effects of CR on the response of normal and GHRKO mice
to insulin stimulation
The actions of insulin are critical for the regulation of the
processes involved in glucose homeostasis. The maintenance of
carbohydrate homeostasis involves multiple enzymatic processes,
in addition to cellular signaling processes, with liver and muscle
playing different roles. To determine the molecular mechanism of
differential impact of CR on insulin sensitivity in normal mice and
GHRKO mice, we evaluated insulin signal transduction through
the IR/IRS/PI3K/AKT1/AKT2 pathway in liver and skeletal
muscle in normal and GHRKO mice fed AL or subjected to CR
for one year in response to an insulin challenge (10 IU/kg insulin
versus saline).
Liver responses to insulin stimulation
Calorie restriction increased total amount of insulin receptor
(IR) protein in normal mice (P,0.03), but did not increase the
already-elevated levels of IR in GHRKO mice on both AL and
CR diets (Figure 2A). The heightened insulin induced upstream
events in GHRKO mice corresponds with previous studies in these
insulin sensitive mutants [23,24]. In response to acute insulin
stimulation, normal mice on CR had a 2-fold greater increase in
IR activation (as estimated by measuring IR phosphorylation at
tyrosine (Tyr) residue 1158 [pY1158] as a proxy for activation)
than the normal AL mice, while CR did not increase the already
elevated insulin-induced IR activation in GHRKO mice
(Figure 2B).
Next, we determined the levels of activation of a major
intracellular signaling intermediate in the insulin signaling
CR, GH, Insulin & Lifespan
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mice, CR significantly increased insulin-induced p85/IRS pY99
phosphorylation from 1.8-fold (N AL) to 2.2-fold in (N CR).
However, this parameter was not affected by CR in GHRKO
mice (Figure 2C). This finding suggests that while the enhanced
amplitude of the insulin signal from the hepatic IR was maintained
at the level of PI3K in normal mice on CR, GHRKO mice on
either diet did not show the level of activation (as presumed by
phosphorylation) that corresponded to the upstream activation of
the insulin receptor (Figure 2B).
An important downstream target of the insulin/PI3K signaling
cascade is protein kinase B (AKT1). Total AKT1 protein in liver
did not differ in any of the groups tested (Figure 2D). In normal
mice, CR increased the insulin-induced phosphorylation of AKT1
at serine (Ser) residue 473 (pS473, a marker of activation of this
enzyme) compared to values measured in insulin-stimulated N AL
mice (P,0.03, Figure 2E). Insulin-induced pS473 levels of AKT in
KO AL and KO CR groups did not significantly differ from the
corresponding values in N AL or N CR mice.
In the liver of normal mice, CR increased AKT2 total protein
compared to AL controls (P,0.03, Figure 2F). GHRKO mice had
comparable AKT2 total protein levels when compared to N AL
mice. Acute insulin stimulation increased the levels of Ser
phosphorylated AKT2 (pS474) in all groups (P,0.001). When
compared to phenotype/treatment saline controls within groups,
insulin increased the phosphorylation in N AL by 92%, while N
Figure 1. Metabolic parameters of male GHRKO (KO) and normal (N) mice fed ad libitum (AL) or subjected to 30% calorie restriction
(CR) for one year. Panel (A) shows time-course changes in body weight over a one year period. After one year of CR, all groups were fasted
overnight and bodyweight (B), peripheral glucose (C), insulin (D), and calculated homeostatic model of assessment (HOMA, E) were determined.
Values with unlike superscripts/letters are significantly different (P,0.05).
doi:10.1371/journal.pone.0004567.g001
CR, GH, Insulin & Lifespan
PLoS ONE | www.plosone.org 3 February 2009 | Volume 4 | Issue 2 | e4567Figure 2. Liver insulin signaling cascade total proteins and phospho-proteins in response to insulin stimulation (10 IU/kg) versus
saline treated controls in GHRKO (KO) and normal (N) mice fed ad libitum (AL) or 30% calorie restricted (CR) for one year. ELISA with
antibodies directed towards total insulin receptor (IR; A), IR pY1158 (B), AKT1 (D), and AKT1 pS473 (E) were performed. Liver homogenates were
immunoprecipitated (IP) with anti-p85, separated using SDS-PAGE and the level of non-specific Tyr phosphorylation was determined at
approximately 180 kDa using anti-pY99 (C). Total AKT2 protein (F) and AKT2 pS473/474 (G) was determined from liver protein homogenates first
CR, GH, Insulin & Lifespan
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in insulin stimulated phosphorylation (N CR 2.1 fold, KO AL 2.05
fold, and KO CR 2.1 fold).
Hepatic insulin signaling cascade activation in response to
insulin stimulation in normal mice on CR and in GHRKO mice
on both diets is compared to N AL controls and summarized in
Figure 2H. These data suggest that CR increases the levels of
proteins involved in insulin signaling transduction and the
activation of these proteins in response to insulin in normal mice,
but has no effects in GHRKO mice. Curiously, the enhanced
activation of the IR in response to insulin stimulation is not
propagated downstream to the AKT proteins in GHRKO mice,
whereas it is in the normal mice. In an attempt to understand this
discrepancy, we explored the regulatory subunits of PI3K in
normal and GHRKO mice fed AL or subjected to 30% CR.
Determination of the PI3K regulatory subunits p85/p55/
p50
To determine the relative protein abundance of the regulatory
subunits of PI3K in the liver, we targeted the p85 subunit of PI3K
for immunoprecipitation in liver homogenates and subsequently
immunoblotted for the p85, p55 and p50 subunits of PI3K
(Figure 3). In the liver of normal mice, CR did not alter p85
(Figure 3A), p55 (Figure 3B) or p50 (Figure 3C) total protein
concentration. Similar to these findings, CR did not alter the level
of these subunits in GHRKO mice, with the exception of a
significant reduction in the p55 subunit compared to GHRKO AL
controls (P,0.05). It has been shown that an alteration in a single
regulatory subunit of PI3K may act to inhibit or bind up free IRS
proteins and alter signal transduction [25,26]. This could explain
the partial decrease in signal amplification seen between the
activation of the IR and PI3K phosphorylation in mice from the
normal CR group. Irrespective of the diet, GHRKO mice had
reduced p85, p55, and p50 regulatory subunits compared to
normal mice. CR did reduce the p55a subunit in GHRKO mice.
We believe this reduction of the regulatory subunits of PI3K in
GHRKO mice may underpin the dampened downstream
activation (compared to activation of IR) of the PI3K/IRS,
AKT1 and AKT2 proteins seen in the insulin stimulation
experiments (Figures 2 and 3).
Effects of insulin stimulation in the skeletal muscle
Skeletal muscle is the major site of insulin-stimulated glucose
uptake in the body, as demonstrated by various tissue-specific
knockouts of the glucose transporter GLUT4 [27]. In normal
mice, CR increased total IR from 6.9260.64 to 8.8760.47 units/
100ug (P,0.02, Figure 4A). In contrast, GHRKO AL mice had
elevated muscle IR protein that was reduced by CR (9.0160.90 to
6.7260.59 units/100ug; P,0.01). Insulin-stimulated phosphory-
lation of the IR in normal CR mice was increased approximately
3-fold compared to AL controls (P,0.001), while IR phosphor-
ylation in GHRKO mice was unaffected by the diet, and values
obtained were comparable to normal AL mice (Figure 4B). This
finding was also reported previously [24], and this does not
correspond with their heightened insulin stimulated glucose uptake
[16] so we therefore further investigated downstream insulin
signaling events associated with insulin mediated glucose uptake.
Calorie restriction produced a significant increase in the PI3K/
IRS phosphorylation of IRS associated with PI3K in the muscle of
normal mice, yet did not further elevate the already heightened
phospho-Tyr levels in the GHRKO mice (Figure 4C). This finding
did not coincide with IR activation, where GHRKO mice did not
show elevations in IR phosphoylation, yet there was an increase in
the level of IRS phosphorylation at Tyr 99. To further probe this
finding, we assessed the total protein and phosphor-Ser levels of
the downstream targets AKT1, AKT2, and mTOR, as well as the
total protein content of GLUT4.
AKT proteins in skeletal muscle are critically involved in
insulin-stimulated glucose uptake through the trafficking of
GLUT4 to the cell surface. In normal mice, CR increased total
AKT1 protein (N AL 11.260.94 versus N CR 16.462.0, P,0.01,
Figure 4D). In contrast, CR did not increase the already-elevated
level of AKT1 total protein in GHRKO mice. Calorie restriction
increased insulin-induced AKT1 phosphorylation in normal mice
(P,0.01), but it did not further increase the already-elevated
AKT1 response to insulin in GHRKO mice (Figure 4E). This data
coincide with the increases of p85/IRS activation in muscle
homogenates shown in Figure 4C.
As mentioned previously, AKT2 has been shown to mediate the
stimulatory effects of CR on improved glucose uptake in skeletal
muscle [27]. Calorie restriction did not alter muscle AKT2 protein
abundance in either phenotype, but total AKT2 protein was
elevated in GHRKO AL mice compared to normal AL controls
(P,0.05, Figure 4F). It should be noted that normal CR mice had
numerically elevated AKT2 values (compared to normal AL mice)
that were not significantly different from the elevated values in
GHRKO groups. Calorie restriction increased AKT2 phosphor-
ylation in response to insulin stimulation in normal mice,
compared to insulin-stimulated AL controls (P,0.01), while
GHRKO mice had elevated phosphor-Ser 474 AKT2 levels
(P,0.01 for both, Figure 4G), with no further changes in response
to CR. The similarity of activated AKT1 and AKT2 between
normal mice on CR and GHRKO mice on either diet coincides
with the improved insulin sensitivity in these groups compared to
normal AL controls, and with our previous results concerning CR
effects on longevity [16]. Since the AKT proteins have been shown
to regulate insulin-stimulated GLUT4 trafficking, we next
determined the level of GLUT4 protein in skeletal muscle whole
cell homogenates.
Muscle GLUT4 total protein levels were significantly increased
by CR in normal mice (P,0.003, Figure 4H). However, CR did
not alter total protein levels in GHRKO mice. Both KO AL and
KO CR mice had elevated muscle GLUT4 total protein levels
compared to N AL controls (P,0.03 and P,0.04, respectively).
These findings indicate that normal mice on CR and GHRKO
mice on both diets have increased pools of GLUT4 available for
recruitment. Figure 4I illustrates/summarizes the insulin signaling
activation state of normal mice on CR and GHRKO mice (on
both diets) compared to normal AL controls. GHRKO mice did
not have elevated IR activation in comparison to their normal
littermates, yet downstream PI3K/IRS-1, AKT1, AKT2 and
GLUT4 levels or activity were elevated. While CR increased the
activation of all proteins tested in normal animals, when compared
to AL controls, the effects of CR in GHRKO mice were absent or
opposite to those found in normal mice on CR. To further
subjected to IP using anti-AKT2. Panel (H) summarizes key insulin-stimulated phospho-proteins compared to insulin-stimulated N AL mice. Bands are
representative blots from 4–6 male mice per phenotype/diet/treatment group. Values with unlike superscripts/letters are significantly different
(P,0.05).
doi:10.1371/journal.pone.0004567.g002
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inhibition between the IR and PI3K signaling molecules.
Calorie restriction and/or GH resistance decreases mTOR
signaling and phosphoSer inhibition of IRS-1 in skeletal
muscle
A number of recent reports show that Ser/Thr kinases mTOR,
JNK, and PKCf mediate a negative feedback loop in the insulin
signaling cascade by phosphorylating IRS-1 at Ser position 307
[28,29]. While IRS proteins are normally Tyr-phosphorylated
upon IR activation, Ser phosphorylation prevents binding to the
beta subunit of the IR and subsequent Tyr phosphorylation,
thereby preventing the progression of insulin signal transduction.
Since we have previously reported a reduction in JNK activation
and in PKCf in the skeletal muscle of GHRKO mice [30], we
investigated the levels of IRS-1 total protein and phospho-Ser307
IRS-1 in normal and GHRKO mice on both dietary regimens.
Total IRS-1 protein levels were not different in any of the groups
tested (Figure 5A). Compared to normal mice, GHRKO mice had
more than a 50% reduction in the phosphorylation of IRS-1 at Ser
307 (Figure 5B). We believe that the decrease in IRS-1
phosphorylation at this inhibitory site (Ser 307) in GHRKO mice
underpins the insulin-stimulated elevations in the activation of
downstream PI3K/IRS, AKT1 and AKT2 in the absence of
increased IR activation upstream.
It was recently reported in another long-lived, insulin-sensitive
mouse, the Ames dwarf, that mTOR signaling was reduced in
skeletal muscle [30]. Since mTOR has been directly implicated in
mediating IRS-1 inhibition through phosphorylation at Ser 307,
we determined the level of mTOR total protein and its
phosphorylated isoform in normal and GHRKO mice on both
diets. In normal mice, CR reduced total mTOR protein compared
to AL controls (P,0.01), while CR did not further reduce the
already low levels of mTOR in GHRKO mice (Figure 6A). The
activation of mTOR through phosphorylation at Ser 2448
followed the same trends as total content of mTOR protein,
where CR reduced basal activation (pS2448) of mTOR in normal
mice but did not alter the already low levels of activation in
GHRKO mice (Figure 6B). We believe that differences in mTOR
signaling implied by these results together with reduced JNK and
PKCf activation previously reported by our laboratory [31]
importantly contribute to, and perhaps account for, the decrease
in skeletal muscle inhibitory IRS-1 Ser 307 phosphorylation and
improved muscle and whole-animal insulin sensitivity in GHRKO
mice.
Conclusion
In the present study, we addressed three major research
questions: 1) Does the GHRKO mutation modulate, or ablate,
the effects of different intensities of CR on longevity? 2) How does
CR improve insulin sensitivity and longevity in normal mice? and
3)Why does CR fail to improve insulin sensitivity and longevity in
GHRKO mice?
In regard to the first question, we showed that while longevity of
normal mice increased as expected in response to various
intensities of CR, GHRKO mice did not derive longevity benefits
from identical dietary interventions. This ‘‘flattening’’ of the
median lifespan response in GHRKO mice on various levels of
food intake shows that, in the absence of a functional GH receptor,
CR does not affect longevity of male GHRKO mice. In other
words, GH resistance ablates, rather than modulates, the key
benefit of CR in these animals. In yeast and invertebrates the
interactions between CR (or dietary restriction) and mutations that
Figure 3. Liver PI3K subunit abundance in GHRKO (KO) and
normal (N) mice fed ad libitum (AL) or 30% calorie restriction
(CR) for one year. Liver protein isolates were immunoprecipitated (IP)
with anti-pan-p85. Total p85a (A), 55a (B) and 50a (C) subunits were
separated using SDS-PAGE, transferred to nitrocellulose membranes
and blotted with anti-pan-p85. Bands are representative blots from 4–6
male mice per phenotype/diet/treatment group. Values with unlike
superscripts/letters are significantly different (P,0.05).
doi:10.1371/journal.pone.0004567.g003
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seems to be homologous insulin signaling pathway mutations that
ablate the CR response in yeast [i.e. Sch9, an AKT homologous
protein and TOR, 33], mutations in chico (IRS-1 homologous
proteins) modulate, rather than block, the CR response in flies
[34]. These findings in less complex organisms are confounded by
two major complications. First, yeast and invertebrates have not
evolved GH signaling pathways. This fact makes it difficult to
interpret findings across species. Second, the method by which
dietary restriction, or CR is delivered in yeast and invertebrates is
quite different than the traditional mammalian model, further
complicating interaction studies [32].
In normal mice on CR, there is a major amplification of the
insulin signaling cascade, with increases in protein concentration
and/or (insulin-stimulated) activation of almost all the cellular
mediators of insulin action tested in the present study (summarized
in Figure 7). These increases in the insulin signaling cascade in
liver and muscle show that the previously documented improve-
ments in whole-animal insulin sensitivity in response to CR reflect
heightened insulin cascade action. We previously postulated that
improved whole-animal insulin sensitivity is tightly coupled to
extended longevity [16].
Figure 4. Muscle insulin signaling cascade total proteins and phospho-proteins in response to insulin stimulation (10 IU/kg) versus
saline treated controls in GHRKO (KO) and normal (N) mice fed ad libitum (AL) or 30% calorie restriction (CR) for one year. Levels of
total insulin receptor (IR; A), IR pY1158 (B), AKT1 (D), and AKT1 pS473 (E) were determined using ELISA. Liver homogenates were immunoprecipitated
(IP) with anti-p85, separated using SDS-PAGE and the level of non-specific Tyr phosphorylation was determined at approximately 180 kDa
(corresponding to IRS proteins) using anti-pY99 (C). Total AKT2 protein (F) and AKT2 pS473/474 (G) was determined from liver protein homogenates
first subjected to IP using anti-AKT2. Total GLUT4 protein (H) was determined in muscle homogenates using anti-GLUT4. Panel (I) summarizes key
insulin-stimulated phospho-proteins compared to insulin-stimulated N AL mice. Bands are representative blots from 4–6 male mice per phenotype/
diet/treatment group. Values with unlike superscripts/letters are significantly different (P,0.05).
doi:10.1371/journal.pone.0004567.g004
Figure 5. Muscle total IRS-1 protein (A) and IRS-1 pS307
inhibitory phosphorylation (B) in GHRKO (KO) and normal (N)
mice fed ad libitum (AL) or 30% calorie restriction (CR) for one
year was determined using ELISA. Bars represent 6–8 animals per
phenotype/diet group. Values with unlike superscripts/letters are
significantly different (P,0.05).
doi:10.1371/journal.pone.0004567.g005
Figure 6. Muscle total mTOR protein (A) and mTOR pS2448 (B)
in GHRKO (KO) and normal (N) mice fed ad libitum (AL) or 30%
calorie restriction (CR) for one year were determined using
western blotting. Bars represent 6–8 animals per phenotype/diet
group.
doi:10.1371/journal.pone.0004567.g006
CR, GH, Insulin & Lifespan
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mutually exclusive—answers to our third question: ‘‘Why does CR
fail to increase insulin sensitivity and longevity in GHRKO mice?’’
Since skeletal muscle is the major mediator of post-prandial,
insulin-stimulated glucose uptake, we believe our data showing
heightened muscle insulin action in both normal mice on CR and
GHRKO mice regardless of diet underpin their improved insulin
sensitivity (summarized in Figure 7). This convergence between
normal mice exposed to long-term CR and innately insulin-
sensitive GHRKO mice could explain why CR fails to further
improve insulin sensitivity of GHRKO mutants or further extend
their already-long lives. Another conclusion can be drawn from
the differential effects of CR on the responses to an insulin
challenge in the liver’s insulin signaling cascade. While normal
mice on CR showed improved downstream insulin action through
increases in total protein and/or insulin-stimulated activation of
several key elements of the insulin signaling cascade in liver, CR
failed to produce corresponding changes in GHRKO mice.
Figure 7. Summarizes the effects of CR, or lack thereof, in wildtype and GHRKO mice under insulin-stimulated conditions. Solid grey
proteins represent stimulatory activation, while solid black proteins are inhibitory.
doi:10.1371/journal.pone.0004567.g007
CR, GH, Insulin & Lifespan
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insulin-induced activation. This tissue-specific phenotypic dimor-
phism may have contributed to the absence of CR effects on whole-
animal insulin sensitivity and lifespan in GHRKO mice.
Collectively, the present study identifies molecular steps of
insulin signaling in the liver and in the muscle that are similarly
affected by two conditions that extend life, CR in normal animals
and deletion of the GH receptor, but are not altered by CR in
GHRKO mice in which CR fails to increase insulin sensitivity and
therefore longevity. This includes four parameters in liver and 8 in
muscle (plus one altered by CR in the opposite directions in the
two phenotypes). We suggest that these steps of insulin signaling
are involved in the control of whole animal insulin sensitivity and
mammalian longevity.
Materials and Methods
Animals
GHRKO and normalmicewereproduced inthe breeding colony
at SIU-SOM Springfield, IL which was developed from mice kindly
providedbyJ.J.Kopchick(Ohio University,Athens).Phenotypically
normal siblings of GHRKO mice served as controls in these studies.
Animals were weaned at 3 weeks of age and placed on Lab Diet
Formula 5001 (Ralston Purina, St. Louis, MO). Animals were
housed at 20–23uC on a 12/12 hour light/dark cycle. Sentinel
animals were sent for serological testing every 3 months and the
results were uniformly negative. These studies were approved by the
Laboratory Animal Use and Care Committee of SIU-SOM.
Longevity Study
The every other day (EOD) feeding paradigm was conducted in
normal and GHRKO mice starting at approximately 8 weeks of
age. Mice were gradually shifted to EOD by placing them on every
third day fast for the first week and then EOD feeding throughout
the remainder of the study. The survival of male mice used in this
study (approximately 15–20 per phenotype/dietary treatment) was
evaluated once all four groups reached median lifespan. At the
time of analysis, the remaining survivors from this still ongoing
study were 6% of the N AL, 43% of the N CR, 41% of the KO AL
and 46% of the KO CR mice. Log-rank analysis for partial
survivorship was conducted. At the time of analysis, all female
treatment groups did not yet reach median lifespan. Animals in the
longevity study were checked daily for health and survival, and
were handled only for cage changes and bi-weekly body
measurements. Animals that appeared near death (listless, unable
to walk, and cold to the touch) or had large bleeding neoplastic
growth approaching 10% of their body weight were euthanized
and date of euthanasia was considered date of death.
Metabolic Parameters
In the mice on the terminal insulin stimulation study, metabolic
parameters were evaluated from blood collected from the orbital
plexus after 10 months of 30% CR. Following a 12 hour fast,
animals were anesthetized using isoflurane (Abbott Laboratories,
Chicago, IL) and glucose levels were determined using a
glucometer (Lifescan, Johnson & Johnson, New Brunswick, NJ.)
and insulin levels were determined using an enzyme-linked
immunosorbant assay (ELISA, Crystal Chem. Inc., Downers
Grove, IL). Homeostatic Model of Assessment (HOMA) score was
calculated as 22.5/(insulin [mU/L] X glucose [mmol/L].
Insulin Stimulation Study
GHRKO mice and phenotypically normal male siblings were
gradually calorie restricted starting at 8 weeks of age, by receiving
90% of the amount of food consumed by AL controls in the initial
week, 80% the following week, and 70% for the remainder of the
study. After one year of 30% CR, mice from all 4 groups (N AL, N
CR, KO AL, and KO CR, n=15–18 per group) were
anesthetized [ketamine (100 mg/ml):xylazine (20 mg/ml), at a
0.1 ml per 10 grams of body weight] and injected in the inferior
vena cava with either 10 IU/kg of porcine insulin (Sigma, St.
Louis, MO) or with saline (control). Liver and hind limb muscle
tissues were extracted and snap frozen at 1 and 3 minutes,
respectively, after injection.
Protein and Phosphoprotein Determination
After storage at 280uC, liver and muscle tissues in T-Per
(Pierce, Rockford, IL) with phosphatase inhibitor (Pierce, Rock-
ford, IL) and protease inhibitors (Sigma, St. Louis, MO) at
approximately 1 ml per 1 g of tissue. ELISA for insulin (Crystal-
Chem, Downers Grove, IL), IR, IR pY1158, IRS-1, IRS-1 pS312,
AKT1 and AKT1 pS473 were used for quantification of cellular
proteins in accordance with manufacturer’s instructions (Biosource
Camarillo, CA).
For immunoprecipitation (IP), equal amounts of solubilized
protein were incubated at 4uC overnight with ,4ug/ml of specific
antibody. Polypeptide-Immuneglobin complexes were then col-
lected by incubation with protein A-sepharose beads (Sigma, St.
Louis, MO) washed solubilization buffer A, and boiled in Laemmli
sample buffer (Biorad, Hercules, CA). Antibodies (Ab) against pan
p85, AKT2, AKT (pS473), mTOR, mTOR (pS2448), and
GLUT4 (Cell Signaling Technology, Inc. Danvers, MA) were
used according to manufacturer’s suggestions. Non-specific IRS
Tyr phosphorylation of p85 was determined by detecting anti-
pY99 (Santa Cruz Biotechnology, Santa Cruz, CA) signal in
,180 kDa region in the anti-pan p85 immunoprecipitates.
Immunoblotting was performed according to standard protocol.
Protein content in tissue homogenates extracted with T-Per
(described above) was determined by the BCA protein assay
(Pierce, Rockford, IL). Protein lysates (40–60 ug) were subjected to
SDS-PAGE using Criterion XT Precast Gels (BioRad, Hercules,
CA), transferred to nitrocellulose membranes (BioRad, Hercules,
CA) and even loading was verified using MemCode Reversible
Protein Stain Kit (Pierce, Rockford, IL). Membranes were blocked
for 1 hour at room temperature with either 5% dry skim milk or
3% BSA when determining phosphorylated proteins, in TBST
(TBS+0.05% Tween-20). Blots were then washed with TBST and
incubated with the primary Ab diluted in the appropriate Ab-
specific blocking solution suggested by the manufacturer. ECL
Plus chemiluminescent reagent was used for immunodetection
(G.E. Healthcare Bio-sciences Corp, Piscataway, NJ). Digital
images of blots were captured using a CCD camera (Hitachi
Genetic Systems, Ameda, CA) and quantified using GeneTools
software (SynGene, Cambridge, England).
Statistical analysis
Kaplan-Meier survival curves were used for survival analysis
using log-rank test to evaluate significance of survivorship between
groups. Median lifespan represents the age at which 50% of the
population within groups remained alive and was reported with
the corresponding hazard ratio (HR) and confidence interval (CI).
Analysis of phenotype X diet was used to reveal interactions of
characterization factors upon the phenotype under analysis, with
subsequent independent Student’s t-tests for within group
comparisons. Analysis of basal and insulin-stimulated protein
concentration across all groups was analyzed with three-way
Analysis of Variance (ANOVA) followed by subsequent two-way
ANOVA’s and Students t-tests within groups when warranted. All
CR, GH, Insulin & Lifespan
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IL) with a=0.05. All graphs were made using Prism 4.02
(GraphPad Software, San Diego CA.). Alpha is set to 0.05. With
the exception of longevity data, all values are reported as
mean6Standard Error of the Mean (SEM) throughout the figures
and text.
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